Ascendis Pharma As Stock Investor Sentiment

ASND Stock  USD 136.08  0.24  0.18%   
About 56% of Ascendis Pharma's investor base is looking to short. The analysis of the overall investor sentiment regarding Ascendis Pharma AS suggests that many traders are alarmed. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.

Panic Vs Confidence

44

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ascendis Pharma's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ascendis Pharma AS.

Ascendis Historical Sentiment

Although Ascendis Pharma's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Ascendis, such as negative comments on social media and news outlets, may cause fear in the market and push Ascendis Pharma's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Ascendis.
  

Ascendis Pharma Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Ascendis Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ascendis Pharma AS Historical Investor Sentiment

Investor biases related to Ascendis Pharma's public news can be used to forecast risks associated with an investment in Ascendis. The trend in average sentiment can be used to explain how an investor holding Ascendis can time the market purely based on public headlines and social activities around Ascendis Pharma AS. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ascendis Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ascendis Pharma and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ascendis Pharma news discussions. The higher the estimate score, the more favorable the investor's outlook on Ascendis Pharma.
over six months ago at news.google.com         
Ascendis Pharma AS Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma Updates Share Capital Structure - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
1616 Shares in Ascendis Pharma AS Purchased by Legato Capital Management LLC - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
ASCENDIS PHARMA AS Revenue Breakdown TRADEGATEA71 TradingView - TradingView
Google News at Macroaxis
over six months ago at zacks.com         
Are Medical Stocks Lagging AdaptHealth This Year?
zacks News
over six months ago at investors.com         
Two Health Care Stocks Outperform SP 500, Offer Entries
Investors Business Daily at Macroaxis
over six months ago at finance.yahoo.com         
Ascendis Pharma AS Rose on Positive Trial Results
Yahoo News
over six months ago at news.google.com         
Ascendis Pharma and MoonLake Immunotherapeutics dropped from Wedbush list By Investing.com - Investi...
Google News at Macroaxis
over six months ago at news.google.com         
When the Price of Talks, People Listen - Stock Traders Daily
Google News at Macroaxis
over six months ago at news.google.com         
Wells Fargo Company Increases Ascendis Pharma AS Price Target to 260.00 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Given Average Rating of Moderate Buy by Analysts - MarketBeat
Google News at Macroaxis
over six months ago at benzinga.com         
Heres How Much 100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
benzinga news
over six months ago at investing.com         
Evercore ISI raises Ascendis Pharma stock target to 191
Investing News at Macroaxis
over six months ago at finance.yahoo.com         
VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China
Yahoo News
over six months ago at thelincolnianonline.com         
Sei Investments Co. Reduces Position in Ascendis Pharma AS
news
Far too much social signal, news, headlines, and media speculation about Ascendis Pharma that are available to investors today. That information is available publicly through Ascendis media outlets and privately through word of mouth or via Ascendis internal channels. However, regardless of the origin, that massive amount of Ascendis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ascendis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ascendis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ascendis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ascendis Pharma alpha.

Ascendis Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Childrens Growth Awareness Week Why Growth Awareness Matters
09/09/2024
2
Ascendis Pharma AS Announces Proposed Public Offering of ADSs
09/18/2024
3
Novo Nordisk Q3 Preview Will 285 Million Weight Loss Bet Offset Bearish Charts
11/05/2024
4
Heres Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical
11/07/2024
5
Ascendis Pharma Q3 2024 Earnings Preview
11/13/2024
6
Sivik Global Healthcare LLC Buys Shares of 10,000 Ascendis Pharma AS
11/14/2024
7
Citi cuts Ascendis Pharma stock target, maintains buy rating on volume growth
11/15/2024
8
Ascendis Pharmas SWOT analysis stock faces growth hurdles amid pipeline promise - Investing.com India
11/22/2024

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stocks Directory
Find actively traded stocks across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments